Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials
{{output}}
Patients with type 2 diabetes (T2D) are at a markedly increased risk of cardiovascular disease (CVD). Dyslipidemia is a common risk factor and a strong predictor of CVD in T2D patients. Although statins decrease the incidence of CVD in T2D, residual cardiovasc... ...
